Ysios Capital

About Ysios Capital

Ysios Capital is a leading life sciences investor funding highly innovative biotech ventures worldwide, with a focus on therapies that address unmet medical needs and have a positive impact on patients and society. The firm supports companies across Europe and the United States, providing the resources and strategic guidance to advance breakthrough therapies, including biotech, gene therapy, and cell therapy programs. Its portfolio spans oncology, neurology, cardiovascular, and other therapeutic areas, backed by an international team with scientific, financial, and entrepreneurial expertise.